20/20 Biolabs, Inc. Common Stock (AIDX) — Free Cash Flow Generation Index
20/20 Biolabs, Inc. Common Stock (AIDX) has a Free Cash Flow Generation Index of 0.95x as of December 2022. Free cash flow of $5.54 Million represents 1% of operating cash flow ($5.80 Million). Explore 20/20 Biolabs, Inc. Common Stock capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
20/20 Biolabs, Inc. Common Stock Free Cash Flow Generation Index (2022–2022)
Historical FCF Generation Index trend for 20/20 Biolabs, Inc. Common Stock across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of 20/20 Biolabs, Inc. Common Stock.
Annual Free Cash Flow Generation for 20/20 Biolabs, Inc. Common Stock (2022–2022)
Year-by-year Free Cash Flow Generation Index for 20/20 Biolabs, Inc. Common Stock. Check cash flow reinvestment rate of 20/20 Biolabs, Inc. Common Stock to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.95x | $5.54 Million | $5.80 Million | $261.79K | — |